The global cardiovascular repair and reconstruction devices market is
expected to reach USD 4,481.5 million by 2025, according to a new report by
Grand View Research, Inc. Increase in the prevalence of Congenital Heart
Defects (CHDs) and the availability of technologically advanced cardiovascular
valves, grafts, and patches are among key factors expected to drive growth over
the forecast period.
Various initiatives by government
organizations for the management of cardiovascular diseases is also expected to
drive growth. For instance, American Heart Association funds research projects
pertaining to CVD. It has funded some breakthrough projects in cardiology, such
as techniques & standards for Cardiopulmonary Resuscitation (CPR), the
first artificial heart valve, cholesterol inhibitors, implantable pacemakers,
drug-eluting stents, and microsurgery. The foundation has funded more than USD
4 billion in the research projects since 1949.
Increase in the demand for effective therapies
that reduce the incidence of adverse cardiac remodeling and help in
regeneration or replacement of the myocardial tissues that get damaged during
ischemic events is also anticipated to boost the cardiovascular repair and
reconstruction devices market over the forecast period. Incidence of various
CVD, such as heart attacks, stroke, and cardiac arrest, is rising owing to
several risk factors such as changes in lifestyle, smoking, alcohol
consumption, physical inactivity, improper nutrition, and obesity. According to
American Heart Association, cardiovascular diseases accounted for about one in
three deaths in the U.S. The medical cost of CHD is anticipated to increase by
nearly 100% between 2013 to 2030. These factors are expected to boost growth
over the forecast period.
Technological advancements in the fields of
material sciences, interventional cardiology, and cryopreservation are also expected
to drive the cardiovascular reconstruction devices market. The use of expanded
PTFE for cardiovascular patches, introduction of transcatheter heart valves,
and the development of minimally invasive technologies, such as transcatheter
aortic valve implantation or transcatheter aortic valve replacement, are among
few factors expected to boost growth over the forecast period. In addition,
developments in cryopreservation techniques by key players such as CryoLife are
among major technological advancements in cardiovascular therapies that are
predicted to positively influence the market.
Browse full research report on Cardiovascular
Repair And Reconstruction Devices Market: https://www.grandviewresearch.com/industry-analysis/cardiovascular-repair-reconstruction-devices-market
Further Key
Findings From the Report Suggest:
- The cardiovascular grafts segment emerged as
the largest segment in 2016 owing to increase in their adoption in pediatric
cardiovascular surgeries for the treatment of CHDs
- The cardiovascular patches segment is
anticipated to be the fastest growing with a growth rate of 6.4%
- Some of the major players operating in this
market are Medtronic; Bard Peripheral Vascular; Terumo Cardiovascular
Systems Corporation; W.L. Gore & Associates, Inc.; Getinge AB;
CryoLife, Inc.; Edwards Lifesciences Corporation; Baxter; and Admedus.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/cardiovascular-repair-reconstruction-devices-market/request/rs1
Grand
View Research has segmented the cardiovascular repair and reconstruction
devices market on the basis of product type and region:
Product
Outlook (Revenue, USD Million, 2014 - 2025)
- Heart Valve Repair
- Cardiovascular
Grafts
- Endovascular stent
graft
- Hemodialysis access
graft
- Peripheral vascular
graft
- Cardiovascular
Patches
- By Application
- Cardiac repair
patches
- Atrial septal
defect
- Common atrium
- Defects of the
endocardial cushion
- Ventricular
septal defect
- Tetralogy of
Fallot
- Suture bleeding
- Vascular repair
patches
- Carotid
endarterectomy
- Anomalous
connection of the pulmonary veins
- Transportation of
the great vessels
- Reconstruction of
the portal and superior mesenteric veins
- others
- By Raw Material
- Synthetic patches
- Biological patches
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment